| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 14 | |
| #2 | Taiwan | 5 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | United States | 4 | |
| #5 | Israel | 3 | |
| #6 | New Zealand | 2 | |
| #7 | Russian Federation | 2 | |
| #8 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Environmental technology | |
| #4 | Machines | |
| #5 | Biotechnology | |
| #6 | Basic materials chemistry |
| # | Name | Total Patents |
|---|---|---|
| #1 | Gagnon Lyne | 31 |
| #2 | Grouix Brigitte | 24 |
| #3 | Laurin Pierre | 20 |
| #4 | Zacharie Boulos | 13 |
| #5 | Abbott Shaun | 9 |
| #6 | Geerts Lilianne | 6 |
| #7 | Penney Christopher | 6 |
| #8 | Bienvenu Jean-Francois | 5 |
| #9 | Leduc Martin | 4 |
| #10 | Perron Valerie | 4 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020113340A1 | Use of sodium 2-(3-pentylphenyl)acetate in the treatment of alström syndrome | |
| EP3203999A1 | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis | |
| TW201441186A | Substituted aromatic compounds and related method for the treatment of fibrosis | |
| TW202045469A | Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis |